Kristen Kliska
Analyst, Kent Office
Replay available
Aquestive Therapeutics, Inc. (AQST) Q4 2025 Earnings Call
Aquestive Therapeutics, Inc. (NASDAQ: AQST) Q4 2025 earnings conference call, held 2026-03-05. Replay captured from the company's public earnings webcast.
Hosted by
Featured presenters
Thomas Fan
Analyst, Lake Street Capital Markets
Dan Barber
President and Chief Executive Officer
Dr. Matthew Davis
Chief Development Officer
Faith Pomeroy Ward
Speaker Host
Rowana Ruiz
Analyst, Learing Partners
Sherry Korchinski
Chief Commercial Officer
Melina Chaffee
Senior Vice President, Regulatory Affairs
Investor webinar replay
Watch the replay and follow the connected company analysis, news, and investor updates for Aquestive Therapeutics, Inc..
Replay transcript excerpt
WEBVTT 00:00:00.031 -- 00:00:04.915 Good day and thank you for standing by. Welcome to Equestrian Therapeutic Support Quarter 00:00:04.915 -- 00:00:10.220 2025 Conference Call. At this time, all participants are in a listen-only mode. 00:00:10.220 -- 00:00:13.143 After the speaker's presentation, there will be a question and answer session. 00:00:13.143 -- 00:00:17.947 To ask a question during the session, you will need to press star 1-1 on your telephone. 00:00:17.947 -- 00:00:21.170 You will then hear an automated message advising your hand is raised. 00:00:21.170 -- 00:00:24.113 Please note that today's conference is being recorded. 00:00:24.113 -- 00:00:26.675 I will now hand the conference over to speaker host for today. 00:00:26.675 -- 00:00:31.198 Faith Pomeroy Ward, please go ahead. 00:00:31.486 -- 00:00:35.532 Thank you, operator. Good morning and welcome to today's call. 00:00:35.532 -- 00:00:41.041 On today's call, I'm joined by Dan Barber, President and Chief Executive Officer, 00:00:41.041 -- 00:00:45.928 and Ernie Toth, Chief Financial Officer, who are going to provide an overview of the 00:00:45.928 -- 00:00:51.096 company's reported financial results for the fourth quarter and full year ended December 00:00:51.096 -- 00:00:53.159 31st, 2025, 00:00:53.159 -- 00:00:58.487 and a progress update on the company's key 2026 objectives, 00:00:58.487 -- 00:01:01.321 followed by a Q&A session. 00:01:01.321 -- 00:01:04.526 During the Q&A session, the team will be joined by Dr. 00:01:04.526 -- 00:01:10.015 Matt Greenhut, Chief Medical Officer, Melina Chaffee, Senior Vice President, 00:01:10.015 -- 00:01:15.123 Regulatory Affairs, Sherry Korchinski, Chief Commercial Officer, 00:01:15.123 -- 00:01:19.650 and Dr. Matthew Davis, Chief Development Officer. 00:01:19.65...